Stock listing

NASDAQ:HLXC Helix Acquisition Corp. III Stock

Home listing (NASDAQ) of Helix Acquisition Corp. III

Follow Helix Acquisition Corp. III into a list and get an email when it puts out news.

Share price · NASDAQ:HLXC

$10.23 USD -0.08 (-0.8%)

Close on Nov 20, 2026

Since Jan 21, 2026 +2.3% · daily closes, Jan 21, 2026 – Nov 20, 2026, adjusted for splits
Day range
$10.22 – $10.27 USDNov 20, 2026
Volume
12,394 sharesNov 20, 2026
Market cap
$181.6M USDAt the close on Nov 20, 2026 · price × 17.75M shares outstanding
Traded on an average day
$377,767 USDMedian day 2,343 shares · 10 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Helix Acquisition Corp. III logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HLXC · Home$10.23 USD-0.08 (-0.8%)12,394$10.25$10.27$10.22$10.31Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HLXC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.23-0.08-0.8%$10.25$10.27$10.2212,394
$10.31+0.03+0.3%$10.31$10.31$10.31359
$10.280.000.0%$10.32$10.32$10.2714
$10.28-0.01-0.1%$10.32$10.32$10.2724,411
$10.29+0.01+0.1%$10.29$10.29$10.291,417
$10.280.000.0%$10.27$10.28$10.2713
$10.280.000.0%$10.27$10.28$10.27788
$10.280.000.0%$10.27$10.29$10.2787,362
$10.28-0.02-0.2%$10.27$10.28$10.2533,078
$10.30+0.01+0.1%$10.27$10.30$10.27184,973
$10.29-0.01-0.1%$10.30$10.30$10.2732,912
$10.30-0.01-0.1%$10.30$10.30$10.30556
$10.310.000.0%$10.30$10.31$10.306,212
$10.31+0.04+0.4%$10.30$10.31$10.306,318
$10.27-0.025-0.2%$10.29$10.29$10.272,487
$10.30-0.015-0.1%$10.30$10.30$10.30166
$10.31+0.02+0.2%$10.30$10.31$10.2922,831
$10.29-0.01-0.1%$10.31$10.31$10.2968,887
$10.30+0.05+0.5%$10.26$10.30$10.2557,744
$10.25+0.03+0.3%$10.20$10.28$10.20168,135
$10.22-0.01-0.1%$10.30$10.30$10.15327,323
$10.23-0.09-0.9%$10.34$10.34$10.2316,513
$10.32-0.01-0.1%$10.33$10.38$10.322,199
$10.33-0.07-0.7%$10.43$10.43$10.333,400
$10.400.000.0%$10.40$10.40$10.4017
$10.40-0.09-0.9%$10.44$10.44$10.35227,000
$10.49-0.01-0.1%$10.36$10.49$10.352,800
$10.500.000.0%$10.50$10.50$10.500
$10.500.000.0%$10.36$10.50$10.36300
$10.50+0.02+0.2%$10.47$10.50$10.463,300
$10.48-0.06-0.6%$10.48$10.48$10.48300
$10.54-0.03-0.3%$10.51$10.60$10.4752,100
$10.570.000.0%$10.57$10.57$10.5740
$10.57-0.05-0.5%$10.60$10.60$10.52900
$10.620.000.0%$10.62$10.62$10.6237
$10.62-0.12-1.1%$10.60$10.68$10.5038,600
$10.74-0.01-0.1%$10.55$10.74$10.5310,611
$10.75-0.19-1.7%$10.59$10.90$10.5527,977
$10.940.000.0%$10.94$10.94$10.9425
$10.94+0.17+1.6%$10.61$10.94$10.50631,300
$10.77+0.17+1.6%$10.70$10.88$10.706,800
$10.600.000.0%$10.60$10.60$10.603,000
$10.600.000.0%$10.60$10.60$10.600
$10.60-0.10-0.9%$10.60$10.60$10.59113,200
$10.70-0.10-0.9%$10.51$10.79$10.358,700
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.65$10.80$10.644,000
$10.80+0.156+1.5%$10.75$10.80$10.751,800
$10.64-0.055-0.5%$10.65$10.65$10.641,100
$10.70-0.051-0.5%$10.65$10.70$10.65700
$10.750.000.0%$10.75$10.75$10.750
$10.750.000.0%$10.80$10.80$10.751,600
$10.750.000.0%$10.75$10.75$10.750
$10.75-0.025-0.2%$10.95$11.05$10.7058,400
$10.78-0.13-1.2%$10.78$10.78$10.78200
$10.91-0.015-0.1%$10.60$10.91$10.60500
$10.92-0.0050.0%$10.75$10.92$10.75600
$10.930.000.0%$10.93$10.93$10.930
$10.930.000.0%$10.93$10.93$10.930
$10.93+0.075+0.7%$10.85$10.99$10.6030,600
$10.85-0.06-0.5%$10.85$10.89$10.789,100
Ticker
NASDAQ:HLXC
Asset type
Stock
Sector
Financials
Industry
Shell companies & SPACs
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Helix Acquisition Corp. III news

Helix Acquisition Corp. III on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
2 in the last 12 months · 2 in all · newest Jan 27, 2026 · oldest 2026

Where Helix Acquisition Corp. III is listed

ListingExchangeCountryCurrency
NASDAQ:HLXC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HLXCBOATSUnited StatesUSD

Valuation

balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$179.4M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
0.04

Shell companies & SPACs: the 10 companies nearest in size, of 284 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Helix Acquisition Corp. III · NASDAQ:HLXCUS$181.6MUS$179.4Mn/an/an/an/an/an/a0.04
Solarius Capital Acquisition Corp. · NASDAQ:SOCAUS$185.7MUS$185.0Mn/an/an/an/an/an/a0.01
Invest Green Acquisition Corporation · NASDAQ:IGACUS$183.9MUS$183.3Mn/an/an/an/an/an/a0.02
McKinley Acquisition Corporation · NASDAQ:MKLYUS$183.7MUS$183.3Mn/an/an/an/an/an/a0.01
Tailwind 2.0 Acquisition Corp. · NASDAQ:TDWDUS$182.2MUS$181.6Mn/an/an/an/an/an/a-0.01
Digital Asset Acquisition Corp. · NASDAQ:DAAQUS$181.6MUS$181.5M34.8×n/an/an/an/an/a0.39
ARC Group Acquisition I Corp · NASDAQ:ARCLUS$180.0MUS$179.1Mn/an/an/a255×n/a0.0×n/a
Apogee Acquisition Corp · NASDAQ:AACPUS$179.9MUS$179.6Mn/an/an/an/an/an/an/a
Twelve Seas Investment Company III · NASDAQ:TWLVUS$179.8MUS$179.5M41.0×n/an/an/an/an/a0.01
SPACSphere Acquisition Corp. · NASDAQ:SSACUS$179.1MUS$3.99M146×n/an/a1.1×n/a0.0×0.00
Proem Acquisition Corp I · NASDAQ:PAACUS$178.1MUS$177.6Mn/an/an/an/an/an/a-0.02
Median of the othersUS$180.8MUS$180.5M41.0×128×0.0×0.01

Events

QuarterResultsShare move
Quarter to May 31, 2026Jun 30, 2026+0.2%
Quarter to Feb 28, 2026Mar 31, 2026−0.9%

Open Events

Financings

RaiseDate
Public offering of class A ordinary shares
Closed: US$172.5M raised · US$10 a share · Leerink Partners +1
Dealers: Leerink Partners (co-lead), Oppenheimer & Co. (co-lead)
Jan 27, 2026
Private placement of class A ordinary shares
Closed: US$4.97M raised · US$10 a share
Buyers: Helix Holdings III LLC (497,500 Class A ordinary shares for $4,975,000)
Insiders: Sold to the company's sponsor, Helix Holdings III LLC
Jan 27, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

A blank check company (SPAC). Priced at US$10.00 a share on Jan 22, 2026.

Price
US$10.00 a share
Shares offered
15,000,000 Class A ordinary shares
Offering size
US$150 million
Underwriters' option
Up to 2,250,000 more shares
Listing
HLXC on the Nasdaq Global Market
Underwriters
Leerink Partners, Oppenheimer & Co. · In the order on the cover
Shares delivered
On or about Jan 26, 2026

Steps

StepWhen
Filed publiclyDec 8, 2025
Amended onceJan 16, 2026
Shares registered with an exchangeJan 22, 2026
Declared effective by the SECJan 22, 2026
Final prospectus, with the priceJan 23, 2026

Open IPO · From the cover of the final prospectus (424B4) filed Jan 23, 2026

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeOct 13, 2026Big-stake noticeSEC
8-K · Current reportAug 17, 2026Current reportSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
All 39 filings
FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 4, 2026Big-stake noticeSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
SCHEDULE 13G · Big-stake noticeFeb 2, 2026Big-stake noticeSEC
8-K · Current reportJan 30, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeJan 30, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJan 30, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedJan 28, 2026Insider tradeSEC
8-K · Current reportJan 27, 2026Material contractSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
424B4 · ProspectusJan 23, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 23, 2026Other filingsSEC
3 · Initial statement of ownershipJan 22, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 22, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 22, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 22, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 22, 2026Insider tradeSEC
S-1MEF · Registration of more shares for the same offeringJan 22, 2026Offer documentSEC
CERT · Exchange's certificate of listingJan 22, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeJan 22, 2026Other filingsSEC
CORRESP · Letter to the SECJan 20, 2026Other filingsSEC
CORRESP · Letter to the SECJan 20, 2026Other filingsSEC
S-1/A · Registration statement, amendedJan 16, 2026Offer documentSEC
UPLOAD · Letter from the SECJan 14, 2026Other filingsSEC
S-1 · Registration statementDec 5, 2025Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Helix Acquisition Corp. III’s releases · as of Jan 27, 2026

Common shares
17,747,500
Fully diluted
17,747,500

Fully diluted

LineShares
Common shares17,747,500

Share count over time

CountShares
Nov 22, 202617,747,500

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Cormorant Asset Management, LP1.3MUS$13.8MNo changeNov 16, 2026
Ra Capital Management, L.P.1.25MUS$13.3MNo changeNov 16, 2026
Nantahala Capital Management, LLC1.25MUS$13.3M−1.25MNov 13, 2026
Silverarc Capital Management, LLC1.21MUS$12.8M+30,209Nov 12, 2026
Decagon Asset Management LLP1.15MUS$12.2M+106KNov 16, 2026
ADAR1 Capital Management, LLC1MUS$10.5MNo changeNov 16, 2026
Balyasny Asset Management L.P.990KUS$10.4MNo changeNov 16, 2026
J. Goldman & Co LP925KUS$9.82M+200KNov 16, 2026
Braidwell LP900KUS$9.47MNo changeNov 16, 2026
Sculptor Capital LP879KUS$9.33M+6,000Nov 13, 2026
All 42 holders
HolderSharesValueChange vs Jun 30Filed
Millennium781KUS$8.3M−84,570Nov 16, 2026
TD627KUS$6.65M+1,610Nov 16, 2026
Affinity Asset Advisors, LLC625KUS$6.64M−625KNov 13, 2026
Commodore Capital LP500KUS$5.31MNo changeNov 16, 2026
Spruce Street Capital LP500KUS$5.31MNo changeNov 13, 2026
Two Sigma272KUS$2.89MNo changeNov 16, 2026
Shaolin Capital Management LLC255KUS$2.71M+155KNov 13, 2026
Sona Asset Management (US) LLC231KUS$2.45M−119KNov 16, 2026
Berkley W R Corp224KUS$2.35MNo changeNov 16, 2026
Hudson Bay Capital Management LP224KUS$2.35MNewNov 13, 2026
EcoR1 Capital, LLC200KUS$2.12MNo changeNov 16, 2026
Laurion Capital Management LP200KUS$2.1MNo changeOct 30, 2026
ExodusPoint Capital Management, LP200KUS$2.12MNo changeNov 16, 2026
Readystate Asset Management LP200KUS$2.1MNo changeNov 16, 2026
DLD Asset Management, LP198KUS$2.1M+2,706Nov 13, 2026
Radcliffe Capital Management, L.P.196KUS$2.08M+22,070Nov 16, 2026
Stempoint Capital LP172KUS$1.82MNo changeNov 16, 2026
RLH Capital LLC150KUS$1.59MNo changeNov 9, 2026
K2 Principal Fund, L.P.150KUS$1.59MNewNov 13, 2026
Periscope Capital Inc.142KUS$1.51MNo changeNov 6, 2026
First Trust118KUS$1.25MNo changeNov 6, 2026
Moore Capital Management, LP100KUS$1.06MNo changeNov 16, 2026
Quarry LP100KUS$1.06MNo changeNov 16, 2026
Lineage Point Capital LP65,816US$699KNewNov 16, 2026
Centiva Capital, LP50,000US$526KNewNov 13, 2026
UBS32,619US$346KNewNov 10, 2026
Abc Arbitrage SA30,000US$319KNo changeOct 23, 2026
Deltec Asset Management LLC25,000US$266KNo changeOct 26, 2026
Clear Street Group Inc.20,497US$218K−5,000Nov 16, 2026
Schonfeld Strategic Advisors LLC16,350US$174K−3,650Nov 16, 2026
Hrt Financial LP11,361US$119K+690Nov 13, 2026
JPMorgan10,144US$108K−2,419Nov 12, 2026

Funds

HolderSharesValueChangeAs of
First Trust Merger Arbitrage Fund102KUS$1.08MNo changeJun 30, 2026
First Trust Multi-Strategy Fund16,122US$171KNo changeJun 30, 2026
Fidelity Nasdaq Composite Index Fund5,890US$60,314No changeMay 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bihua Chen
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past)
Chairperson and CEO, Director · Since at least Jan 22, 2026
John Schmid
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past)
Director · Since at least Jan 22, 2026
Mark McKenna
Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Spyre Therapeutics, Inc. (Board Member · Since at least Feb 1, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Prometheus Biosciences Inc (Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past)
Director · Since at least Jan 22, 2026
Caleb Tripp
Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Financial Officer · Since at least Feb 8, 2024); BridgeBio Pharma, Inc. (Chief Financial Officer · Feb 28, 2025 – Nov 4, 2026 · Past)
CFO & COO · Since at least Jan 22, 2026
Nebojsa Obradovic
Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Legal Officer · Since at least Feb 8, 2024)
Chief Legal Officer · Since at least Jan 22, 2026

Open People

Log in to ask 6ix AI your own questions about Helix Acquisition Corp. III.